BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 35108516)

  • 1. Erythrocyte transglutaminase-2 combats hypoxia and chronic kidney disease by promoting oxygen delivery and carnitine homeostasis.
    Xu P; Chen C; Zhang Y; Dzieciatkowska M; Brown BC; Zhang W; Xie T; Abdulmalik O; Song A; Tong C; Qi H; Roach R; Kellems RE; D'Alessandro A; Xia Y
    Cell Metab; 2022 Feb; 34(2):299-316.e6. PubMed ID: 35108516
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Erythrocyte Metabolic Reprogramming by Sphingosine 1-Phosphate in Chronic Kidney Disease and Therapies.
    Xie T; Chen C; Peng Z; Brown BC; Reisz JA; Xu P; Zhou Z; Song A; Zhang Y; Bogdanov MV; Kellems RE; D'Alessandro A; Zhang W; Xia Y
    Circ Res; 2020 Jul; 127(3):360-375. PubMed ID: 32284030
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Erythrocyte adaptive metabolic reprogramming under physiological and pathological hypoxia.
    D'Alessandro A; Xia Y
    Curr Opin Hematol; 2020 May; 27(3):155-162. PubMed ID: 32141895
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Erythrocyte Adenosine A2B Receptor-Mediated AMPK Activation: A Missing Component Counteracting CKD by Promoting Oxygen Delivery.
    Peng Z; Luo R; Xie T; Zhang W; Liu H; Wang W; Tao L; Kellems RE; Xia Y
    J Am Soc Nephrol; 2019 Aug; 30(8):1413-1424. PubMed ID: 31278195
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Erythrocyte ENT1-AMPD3 Axis is an Essential Purinergic Hypoxia Sensor and Energy Regulator Combating CKD in a Mouse Model.
    Chen C; Xie T; Zhang Y; Wang Y; Yu F; Lin L; Zhang W; Brown BC; Zhang X; Kellems RE; D'Alessandro A; Xia Y
    J Am Soc Nephrol; 2023 Oct; 34(10):1647-1671. PubMed ID: 37725437
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Erythrocyte adenosine A2B receptor prevents cognitive and auditory dysfunction by promoting hypoxic and metabolic reprogramming.
    Qiang Q; Manalo JM; Sun H; Zhang Y; Song A; Wen AQ; Wen YE; Chen C; Liu H; Cui Y; Nemkov T; Reisz JA; Edwards Iii G; Perreira FA; Kellems RE; Soto C; D'Alessandro A; Xia Y
    PLoS Biol; 2021 Jun; 19(6):e3001239. PubMed ID: 34138843
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Beneficial Role of Erythrocyte Adenosine A2B Receptor-Mediated AMP-Activated Protein Kinase Activation in High-Altitude Hypoxia.
    Liu H; Zhang Y; Wu H; D'Alessandro A; Yegutkin GG; Song A; Sun K; Li J; Cheng NY; Huang A; Edward Wen Y; Weng TT; Luo F; Nemkov T; Sun H; Kellems RE; Karmouty-Quintana H; Hansen KC; Zhao B; Subudhi AW; Jameson-Van Houten S; Julian CG; Lovering AT; Eltzschig HK; Blackburn MR; Roach RC; Xia Y
    Circulation; 2016 Aug; 134(5):405-21. PubMed ID: 27482003
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recent advances in drug delivery via the organic cation/carnitine transporter 2 (OCTN2/SLC22A5).
    Kou L; Sun R; Ganapathy V; Yao Q; Chen R
    Expert Opin Ther Targets; 2018 Aug; 22(8):715-726. PubMed ID: 30016594
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sphingosine-1-phosphate promotes erythrocyte glycolysis and oxygen release for adaptation to high-altitude hypoxia.
    Sun K; Zhang Y; D'Alessandro A; Nemkov T; Song A; Wu H; Liu H; Adebiyi M; Huang A; Wen YE; Bogdanov MV; Vila A; O'Brien J; Kellems RE; Dowhan W; Subudhi AW; Jameson-Van Houten S; Julian CG; Lovering AT; Safo M; Hansen KC; Roach RC; Xia Y
    Nat Commun; 2016 Jul; 7():12086. PubMed ID: 27417539
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SLC22A5 (OCTN2) Carnitine Transporter-Indispensable for Cell Metabolism, a Jekyll and Hyde of Human Cancer.
    Juraszek B; Nałęcz KA
    Molecules; 2019 Dec; 25(1):. PubMed ID: 31861504
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypoxia-inducible factor-1α activation improves renal oxygenation and mitochondrial function in early chronic kidney disease.
    Thomas JL; Pham H; Li Y; Hall E; Perkins GA; Ali SS; Patel HH; Singh P
    Am J Physiol Renal Physiol; 2017 Aug; 313(2):F282-F290. PubMed ID: 28331062
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clozapine-induced reduction of l-carnitine reabsorption via inhibition/down-regulation of renal carnitine/organic cation transporter 2 contributes to liver lipid metabolic disorder in mice.
    Wang W; Bai M; Jiang T; Li C; Li P; Zhou H; Wang Z; Li L; Jiang H
    Toxicol Appl Pharmacol; 2019 Jan; 363():47-56. PubMed ID: 30465787
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    Fink MA; Paland H; Herzog S; Grube M; Vogelgesang S; Weitmann K; Bialke A; Hoffmann W; Rauch BH; Schroeder HWS; Bien-Möller S
    Clin Cancer Res; 2019 May; 25(9):2874-2886. PubMed ID: 30670496
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interactions between HIF-1α and AMPK in the regulation of cellular hypoxia adaptation in chronic kidney disease.
    Li H; Satriano J; Thomas JL; Miyamoto S; Sharma K; Pastor-Soler NM; Hallows KR; Singh P
    Am J Physiol Renal Physiol; 2015 Sep; 309(5):F414-28. PubMed ID: 26136559
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cotransporting Ion is a Trigger for Cellular Endocytosis of Transporter-Targeting Nanoparticles: A Case Study of High-Efficiency SLC22A5 (OCTN2)-Mediated Carnitine-Conjugated Nanoparticles for Oral Delivery of Therapeutic Drugs.
    Kou L; Yao Q; Sun M; Wu C; Wang J; Luo Q; Wang G; Du Y; Fu Q; Wang J; He Z; Ganapathy V; Sun J
    Adv Healthc Mater; 2017 Sep; 6(17):. PubMed ID: 28661032
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutual antagonism between hypoxia-inducible factors 1α and 2α regulates oxygen sensing and cardio-respiratory homeostasis.
    Yuan G; Peng YJ; Reddy VD; Makarenko VV; Nanduri J; Khan SA; Garcia JA; Kumar GK; Semenza GL; Prabhakar NR
    Proc Natl Acad Sci U S A; 2013 May; 110(19):E1788-96. PubMed ID: 23610397
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute Exercise Stimulates Carnitine Biosynthesis and OCTN2 Expression in Mouse Kidney.
    Broderick TL; Cusimano FA; Carlson C; Tamura LK
    Kidney Blood Press Res; 2017; 42(3):398-405. PubMed ID: 28668962
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Erythrocyte purinergic signaling components underlie hypoxia adaptation.
    Sun K; Liu H; Song A; Manalo JM; D'Alessandro A; Hansen KC; Kellems RE; Eltzschig HK; Blackburn MR; Roach RC; Xia Y
    J Appl Physiol (1985); 2017 Oct; 123(4):951-956. PubMed ID: 28572494
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypoxia and the HIF system in kidney disease.
    Nangaku M; Eckardt KU
    J Mol Med (Berl); 2007 Dec; 85(12):1325-30. PubMed ID: 18026918
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of mammalian O2 homeostasis by hypoxia-inducible factor 1.
    Semenza GL
    Annu Rev Cell Dev Biol; 1999; 15():551-78. PubMed ID: 10611972
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.